-
Doctors' benevolence, excellence: "2022 Breast Cancer Elite Practice and Exchange Project - Weihai Station" ended successfully
Time of Update: 2022-11-14
Case 3 Sharing: Dr. Mao Yan (Breast Disease Diagnosis and Treatment Center, The Affiliated Hospital of Qingdao University)The patient, 43 years old, was diagnosed with breast malignancy (left, cT2N1M1), stage IV, Luminal type B, bone secondary malignancy, PR(-), Her-2(1+)) in 2018.
-
Yin Yuxin's team discovered a new mechanism of long-distance communication between organs: lung tissue extracellular vesicles regulate bone marrow
Time of Update: 2022-09-07
It has been found that lung tumors can remotely activate osteoblasts in the bone and induce Siglec-F high To solve the above problems, Yin Yuxin's team successfully established an efficient method to collect high-quality EVs from human and mouse normal lung tissues .
-
A&R: A risk score for detecting subclinical rheumatoid arthritis-associated interstitial lung disease
Time of Update: 2022-08-12
. Conclusions: This study identifies and validates a risk score for RA-ILD with or without MUC5B rs35705950 that identifies patients at high risk for subclinical RA-ILD requiring screening with chest HRCT scans .
-
If your blood pressure rises when you stand, you may be at risk of a heart attack
Time of Update: 2022-04-25
In this study, the researchers assessed whether the opposite response -- a marked increase in systolic blood pressure while standing -- is a risk factor for heart attack and other serious cardiovascular events .
-
ACC: Evidence of QT interval prolongation in COVID-19 patients treated with hydroxychloroquine
Time of Update: 2022-04-24
QT prolongation is one of the most common reasons for drug withdrawal from the market by disrupting human ether-a-go-go-related gene ( hERG ) K + channel function .
Correspondingly, chronic and acute treatment of HCQ reduced hERG currents .
Conclusion: We conclude that HCQ reduces mature hERG channel expression and I hERG
-
Daratumumab may be an effective maintenance strategy after ASCT in NDMM patients
Time of Update: 2022-02-23
RESULTS: Study process and patient characteristics Between May 30, 2016, and June 18, 2018, 886 patients with ≥ partial response (PR) in Part 1 were randomly assigned to daratumumab maintenance therapy ( 442 cases) or observation group (444 cases) (Figure 1) .
-
Yaohua Medicine's rare blood disease drug Besremi obtains FDA approval for listing
Time of Update: 2021-12-07
The injected drug is approved for the treatment of adult patients with polycythemia vera, a rare blood disease that causes blood to thicken and affects approximately 6,200 people in the United States each year .
-
ACR 2021: A meta-analysis of pregnancy outcomes in Behcet's disease
Time of Update: 2021-12-02
The purpose of our work is to assess the prevalence of fetal and maternal complications through systematic reviews and meta-analysis to determine the impact of Behcet's disease on pregnancy .
Behcet's Disease: A Meta-analysis of Pregnancy Outcomes [ abstract].
org/abstract/behcets-disease-a-meta-analysis-of-pregnancy-outcomes/.
-
Unexpected types of antibodies found in people infected with malaria
Time of Update: 2021-11-12
In this new study, the research team looked at antibodies collected in the blood of 54 adult study participants infected with malaria in the laboratory, either through direct injections into the bloodstream or through mosquito bites .
-
Co-founded by Dr. Wang Xiaodong
Time of Update: 2021-09-19
RIP1 inhibitor According to the official website of Viterilon, in animal experiments, inhibiting RIP1 kinase through small molecule drugs or gene editing can effectively prevent or reduce the development of a series of diseases , including multiple sclerosis (EAE model), Alzheimer's disease, amyotrophic lateral sclerosis, systemic inflammatory response syndrome .
-
Research: the new coronavirus may be concerned about spreading in the late summer of 2019
Time of Update: 2021-08-26
An international research team recently released a preprint paper saying that the researchers tested positive for the new coronavirus ribonucleic acid in a sample collected by a measles and other disease surveillance project in Italy in September 2019, which means that the new crown virus.
-
Sanofi intends to acquire Translate Bio, a US biotechnology company, for US$3.2 billion to fill in the shortcomings of mRNA technology
Time of Update: 2021-08-13
The clinical-stage lung products of the mRNA platform are being tested as inhalation treatments for cystic fibrosis in phase I/II clinical trials, and are being studied in areas such as liver disease and oncology .
-
Italfarmaco obtained the exclusive commercial rights of Luye Pharma's Lismindo Day transdermal patch
Time of Update: 2021-07-17
According to the agreement, Italfarmaco has the exclusive right to commercialize Liss’ Mindoday patch in Germany, Italy, Portugal and Greece (the "region") .
-
Arikayce approved in Japan: the first treatment of non-tuberculous branches caused by MAC
Time of Update: 2021-05-03
Original source: ARIKAYCE® (amikacin liposome inhalation suspension) approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients with NTM Lung Disease Caused by MAC Who Did Not Sufficiently Respond to Prior Treatment with MDR
-
Ishii to Science: "Trump owes us an apology
Time of Update: 2020-12-03
: We detected SARS-CoV-2 nucleic acid in environmental samples from the South China seafood market, including curtain door handles, floors and sewage, with very low gene copies.
